Sesen Bio, Inc. (26)

Browse by Contract Category

Contracts

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 15, 2021)
Exclusive License Agreement, dated July (Filed With SEC on November 9, 2020)
Form of Indemnification Agreement by and between Sesen Bio, Inc. and Each of its Directors and Executive Officers (Filed With SEC on March 16, 2020)
Stock Option Award Agreement, dated August 1, 2019, by and between Sesen Bio, Inc. and Monica Forbes (Filed With SEC on November 12, 2019)
Employment Agreement, dated July 26, 2019, by and between Mark R. Sullivan and Sesen Bio, Inc (Filed With SEC on November 12, 2019)
Amendment No. 2 to the Open Market Sale Agreement (Filed With SEC on February 17, 2021)
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)
Open Market Sale AgreementSM, dated November 29, 2019, by and between Sesen Bio, Inc. and Jefferies LLC (Filed With SEC on November 29, 2019)
Form of 2018 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
Form of 2017 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
Amendment to Securities Purchase Agreement, dated October 28, 2019, by and among Sesen Bio, Inc. and the undersigned parties thereto (Filed With SEC on October 29, 2019)
Form of 2018 Warrant Amendment Agreement (Filed With SEC on October 29, 2019)
Form of 2017 Warrant Exercise Agreement (Filed With SEC on October 29, 2019)
Employment Agreement, dated August 26, 2019, by and between Monica Forbes and Sesen Bio, Inc (Filed With SEC on August 26, 2019)
Form of Indemnification Agreement, by and between Sesen Bio, Inc. and each of its directors and executive officers (Filed With SEC on August 26, 2019)
Press Release, dated August 26, 2019 (Filed With SEC on August 26, 2019)
Separation and General Release, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)
Consulting Agreement, dated August 2, 2019, by and between Sesen Bio, Inc. and Dennis Kim (Filed With SEC on August 8, 2019)
Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on August 8, 2019)
2014 Stock Incentive Plan, as amended (Filed With SEC on June 25, 2019)
Form of Warrant (Filed With SEC on June 19, 2019)
Underwriting Agreement, dated June 19, 2019 (Filed With SEC on June 19, 2019)
Employment Agreement, dated September 20, 2016, by and between Eleven Biotherapeutics, Inc. and Glen MacDonald, as amended on February 21, 2017 (Filed With SEC on May 10, 2019)
Stock Option Award Agreement, dated December 3, 2018, by and between Sesen Bio, Inc. and Dennis Kim, M.D (Filed With SEC on March 1, 2019)
Master Bioprocessing Services Agreement, dated October 4, 2018, between Sesen Bio, Inc. and FUJIFILM Diosynth Biotechnologies U.S.A., Inc (Filed With SEC on March 1, 2019)
Stock Option Award Agreement, dated August 7, 2018, by and between Sesen Bio, Inc. and Thomas R. Cannell, D.V.M (Filed With SEC on March 1, 2019)